Conditional deletion reveals a cell-autonomous requirement of SLP-76 for thymocyte selection

Jonathan S Maltzman1, Lisa Kovoor, James L Clements

  • 1Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

Insights

SH2 domain-containing leukocyte phosphoprotein of 76 kD (SLP-76) is essential for T cell maturation and signaling. Conditional deletion of SLP-76 after the DN3 stage reveals its critical role in mature T cell receptor signal transduction.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • The SH2 domain-containing leukocyte phosphoprotein of 76 kD (SLP-76) is crucial for T cell development.
  • Complete SLP-76 deficiency causes a block at the double-negative 3 (DN3) stage, limiting study of its role in later T cell stages.

Purpose of the Study:

  • To investigate the function of SLP-76 in alphabeta T cell receptor (TCR) signal transduction in primary thymocytes and peripheral T cells.
  • To overcome the developmental block by conditionally deleting SLP-76 after the DN3 stage.

Main Methods:

  • Cre-loxP system to generate mice with conditional deletion of SLP-76.
  • Analysis of thymocyte and peripheral T cell populations, including surface phenotype, cellularity, and calcium flux.

Main Results:

  • Conditional SLP-76 deletion allowed development to the CD4+CD8+ double positive (DP) stage but impaired positive selection and activation-induced cell death.
  • DP thymocytes lacking SLP-76 showed reduced cellularity and failed positive selection to single positive (SP) stages.
  • Generated CD4+ SP thymocytes exhibited defective calcium flux upon alphabeta TCR stimulation.
  • Peripheral T cells were reduced in number, lacked SLP-76, and displayed an abnormal surface phenotype.

Conclusions:

  • SLP-76 is indispensable for signal transduction mediated by the mature alphabeta TCR in primary T lineage cells.
  • This study provides the first direct evidence for SLP-76's requirement in alphabeta TCR signaling post-DN3 stage development.